Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination
The company has started manufacturing the Sputnik Light vaccine
Sputnik M is a new member of the Sputnik vaccines family
According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)